Mitogen-Activated Protein Kinase-Dependent Interleukin-1a Intracrine Signaling Is Modulated by YopP during Yersinia enterocolitica Infection
Infect. Immun., Jan 2012; 80: 289 - 297.
[IL1A]
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype
Carcinogenesis, Jan 2012; 10.1093/carcin/bgs007.
[ETS1
]
PNAS Plus: TANK-binding kinase 1 (TBK1) controls cell survival through PAI-2/serpinB2 and transglutaminase 2
PNAS, Jan 2012; 109: E177 - E186.
[SERPINB2
]
Heparanase and Syndecan-1 Interplay Orchestrates Fibroblast Growth Factor-2-induced Epithelial-Mesenchymal Transition in Renal Tubular Cells
J. Biol. Chem., Jan 2012; 287: 1478 - 1488.
[HPSE
]
RBFOX1 (Gene ID 54715) Human shRNA
To view the shRNA sequence, please register your email:
Email:
Specifications
Related Products
Product Manual
FAQs
Catalog No.
Description
Vector
Price
Shipping
TG307579
RBFOX1 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector (Gene ID = 54715). 5µg purified plasmid DNA per construct
Summary: Ataxin-2 binding protein 1 has an RNP motif that is highly conserved among RNA-binding proteins. This protein binds to the C-terminus of ataxin-2 and may contribute to the restricted pathology of spinocerebellar ataxia type 2 (SCA2). Ataxin-2 is the gene product of the SCA2 gene which causes familial neurodegenerative diseases. Ataxin-2 binding protein 1 and ataxin-2 are both localized in the trans-Golgi network. Several alternatively spliced transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been found but their full length nature has not been determined. [provided by RefSeq].
shRNA Design:
These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, align it with our published shRNA design sequences. If these do not align, please utilize our custom shRNA service.
Performance Guranteed:
OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples.
For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred).
* Delivery time in business days.
Researchers who bought this RNAi have also purchased:
